检索结果-南通市图书馆

Journal of Intensive Medicine 2023年第2期3卷 89-103页

作者： Stavros Eftychiou Antonis Kalakoutas Alastair Proudfoot Barts Health NHS Trust London E11FRUK Barking Havering and Redbridge University Hospitals NHS TrustRomford RM70AGUK Barts and the London School of Medicine and Dentistry London E12ADUK Department of Perioperative Medicine Barts Heart CentreSt Bartholomew’s HospitalLondon EC1A 7BEUK Queen Mary University of London London EC1M 6BQUK Department of Anaesthesiology and Intensive Care German Heart Centre BerlinBerlin 13353Germany

Cardiogenic shock(CS)is a complex clinical syndrome with a high mortality *** can occur to due to multiple etiologies of cardiovascular disease and is phenotypically *** myocardial infarction-related CS(AMI-CS)has historically been the most prevalent cause,and thus,research and guidance have focused primarily on *** data suggest that the burden of non-ischemic CS is increasing in the population of patents requiring intensive care *** is,however,a paucity of data and guidelines to inform the management of these patients who fall into two broad groups:those with existing heart failure and CS and those with no known history of heart failure who present with"de novo"*** use of temporary mechanical circulatory support(MCS)has expanded across all etiologies,despite its high cost,resource intensity,complication rates,and lack of high-quality outcome ***,we discuss the currently available evidence on the role of MCS in the management of patients with de novo CS to include fulminant myocarditis,right ventricular(RV)failure,Takotsubo syndrome,post-partum cardiomyopathy,and CS due to valve lesions and other cardiomyopathies.

关键词： Cardiogenic shock Heart failure Critical care mechanical circulatory support Takotsubo cardiomyopathy Peripartum cardiomyopathy

Integrated management of cardiac failure:the cardiac failure clinic

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Frontiers of Medicine 2011年第1期5卷 20-25页

作者： Daniel LOISANCE La Pitie Hospital Paris 75013France

The prevalence of the risk factors and the risk of cardiac failure are both increasing in *** might be the consequence of the changes of the life conditions(emigration to the urban areas,changes in the diet and life style,lack of physical exercise,etc.).The wide range of clinical presentations of cardiac failure(acute or chronic)and of therapeutic approaches(medical or surgical)makes necessary the integration within the same structure of the various experts involved in the diagnosis and the treatment of cardiac *** and human resources required to offer all the options represent a multifaceted commitment which should be focused optimally in dedicated *** these centers,collaboration should replace competition between the medical and the surgical cardiac *** of team work should permit to optimize the cost efficacy of the *** of all,such a structure will facilitate the translation of innovative therapies between the research centers and clinical facilities.

关键词： cardiac failure cardiac transplantation mechanical circulatory support

Pharmacological strategies in extracorporeal membrane oxygenation weaning failure: a call to action

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Emergency and Critical Care Medicine 2023年第2期3卷 43-45页

作者： Francisco J.González-Ruiz Francisco M.Baranda-Tovar Luis A.Baeza-Herrera JoséD.Utrilla-Álvarez Ricardo E.Quirázco-Cordova Gustavo Rojas-Velasco Department of Cardiovascular Critical Care National Institute of Cardiology“Dr.Ignacio Chávez”Mexico CityMexico National Institute of Cardiology.Juan Badiano 1 Belisario Dominguez Secc 16Tlalpan14080Mexico CityMexico

Extracorporeal membrane oxygenation has emerged as a viable alternative for stabilizing and improving critically ill patients in acute cardiovascular ***,the weaning stage has been associated with a high morbidity and mortality *** makes searching for strategies that reduce failure in this final process *** a new approach must be tried and included in our protocols,seeking the patient’s well-being at all *** this article,the authors discuss their point of view regarding potential pharmacological alternatives and the mechanism of action involved,which could decrease the mortality associated with this therapeutic.

关键词： β-Blockers Extracorporeal membrane oxygenation Inodilators mechanical circulatory support Pharmacological strategies

Status on Heart Transplantation in China

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Chinese Medical Journal 2015年第23期128卷 3238-3242页

作者： Xing-Jian Hu Nian-Guo Dong Jin-Ping Liu Fei Li Yong-Feng Sun Yin Wang Department of Cardiovascular Surgery Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei 430022 China Organ Transplantation Center Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei 430022 China

INTRODUCTION ＂End-stage heart disease＂ commonly refers to an irreversible stage of cardiac decompensation caused by a variety of pathologies that cannot be treated using conventional drugs or traditional surgical treatments. The life expectancy of patients with end-stage heart disease ranges from 〈6 months to 1 year. Therapeutic strategies for end-stage heart disease patients are primarily based on three approaches： Internal medicine therapy, surgical therapy （heart transplantation）, and multiple organ protection therapy via the core method of mechanical circulation assistance. Among these approaches, heart transplantation has become recognized as the most efl＇ective treatment.

关键词： Donation After Brain Death Elderly Heart Transplantation Marginal Donor Heart mechanical circulatory support Pediatric

To ventricular assist devices or not:When is implantation of a ventricular assist device appropriate in advanced ambulatory heart failure?

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

World Journal of Cardiology 2016年第12期8卷 695-702页

作者： Emily Cerier Brent C Lampert Arman Kilic Asia McDavid Salil V Deo Ahmet Kilic Division of Cardiac Surgery The Ohio State University Wexner Medical Center Division of Cardiovascular Medicine the Ohio State University Wexner Medical Center Division of Cardiovascular Surgery Hospital of the University of Pennsylvania Harrington Heart and Vascular Institute University HospitalsCase Western Reserve University

Advanced heart failure has been traditionally treated via either heart transplantation,continuous inotropes,consideration for hospice and more recently via left ventricular assist devices(LVAD).Heart transplantation has been limited by organ availability and the futility of other options has thrust LVAD therapy into the mainstream of therapy for end stage heart *** in technology and survival combined with improvements in the quality of life have made LVADs a viable option for many patients suffering from heart *** question of when to implant these devices in those patients with advanced,yet still ambulatory heart failure remains a controversial *** discuss the current state of LVAD therapy and the risk vs benefit of these devices in the treatment of heart failure.

关键词： Left ventricular assist device mechanical circulatory support Heart failure Cardiomyopathy Diastolic dysfunction

Extra-corporeal membrane oxygenation in aortic surgery and dissection: A systematic review

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Critical Care Medicine 2019年第8期8卷 135-147页

作者： Massimo Capoccia Marc O Maybauer Department of Aortic and Cardiac Surgery Royal Brompton HospitalRoyal Brompton and Harefield NHS Foundation TrustLondon SW36NPUnited Kingdom Department of Anaesthesia Manchester Royal InfirmaryManchester University NHS Foundation TrustManchester M139WLUnited Kingdom Department of Anaesthesiology and Intensive Care Medicine Phillips UniversityMarburg 35037Germany Critical Care Research Group The Prince Charles Hospital and The University of QueenslandBrisbane QLD 4032QueenslandAustralia Advanced Critical Care and Transplant Institute Integris Baptist Medical CentreOklahoma CityOK 73112United States

BACKGROUND Very little is known about the role of extracorporeal membrane oxygenation(ECMO)for the management of patients undergoing major aortic surgery with particular reference to aortic *** To review the available literature to determine if there was any *** A systematic literature search through PubMed and EMBASE was undertaken according to specific key *** The search resulted in 29 publications relevant to the subject:1 brief communication,1 surgical technique report,1 invited commentary,1 retrospective case review,1 observational study,4 retrospective reviews,13 case reports and 7 conference abstracts.A total of 194 patients were included in these publications of whom 77 *** Although there is no compelling evidence for or against the use of ECMO in major aortic surgery or dissection,it is enough to justify its use in this patient population despite current adverse attitude.

关键词： Aortic dissection Aortic surgery Extra-corporeal life support Extracorporealmembrane oxygenation Extracorporeal life support mechanical circulatory support

Optimal timing of same-admission orthotopic heart transplantation after left ventricular assist device implantation

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Cardiology 2017年第2期9卷 154-161页

作者： Gunsagar Gulati David Ouyang Richard Ha Dipanjan Banerjee Depart-ment of Medicine Stanford University School of Medicine Department of Cardiothoracic Surgery Division of Adult Cardiac SurgeryStanford University

AIM To investigate the impact of timing of same-admission orthotopic heart transplant(OHT) after left ventricular assist device(LVAD) implantation on in-hospital mortality and post-transplant length of *** Using data from the Nationwide Inpatient Sample from 1998 to 2011, we identified patients 18 years of age or older who underwent implantation of a LVAD and for whom the procedure date was available. We calculated in-hospital mortality for those patients who underwent OHT during the same admission as a function of time from LVAD to OHT, adjusting for age, sex, race, household income, and number of comorbid diagnoses. Finally, we analyzed the effect of time to OHT after LVAD implantation on the length of hospital stay *** Two thousand and two hundred patients underwent implantation of a LVAD in this cohort. One hundred and sixty-four(7.5%) patients also underwent OHT duringthe same admission, which occurred on average 32 d(IQR 7.75-66 d) after LVAD implantation. Of patients who underwent OHT, patients who underwent transplantation within 7 d of LVAD implantation("early") experienced increased in-hospital mortality(26.8% vs 12.2%, P = 0.0483) compared to patients who underwent transplant after 8 d("late"). There was no statistically significant difference in age, sex, race, household income, or number of comorbid diagnoses between the early and late groups. Post-transplant length of stay after LVAD implantation was also not significantly different between patients who underwent early vs late OHT. CONCLUSION In this cohort of patients who received LVADs, the rate of in-hospital mortality after OHT was lower for patients who underwent late OHT(at least 8 d after LVAD implantation) compared to patients who underwent early OHT. Delayed timing of OHT after LVAD implantation did not correlate with longer hospital stays post-transplant.

关键词： mechanical circulatory support Orthotopic heart transplant Bridge to transplant Left ventricular assist device outcomes